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INTRODUCTION
Salicylates are commonly used for their analgesic, antipyretic, 
anti-inflammatory and antiplatelet properties. Acute salicylate 
poisoning is a common overdose resulting in high morbidity 
and mortality. Insidious cases of salicylate intoxication may 
also occur, caused by either ingestion or topical absorption, 
most often in elderly patients with associated medical illnesses. 
We present a fatal case of acute methyl salicylate toxicity from 
both ingestion and dermal absorption of oil of wintergreen. This 
case highlights the point that topical absorption of salicylates, 
particularly in patients with renal failure, can result in severe 
intoxication. 
CASE REPORT
An 80-year-old man with end-stage renal disease had oil of 
wintergreen (containing 35% mg/ml methyl salicylate) rubbed 
regularly on his lower extremities by a live-in attendant. He 
applied it to the patient’s legs and left the bottle on the nightstand. 
The  patient  mistakenly  drank  a  mouthful  when  he  mistook 
it for a beverage. The attendant said the patient vomited the 
oil of wintergreen immediately. Two hours later, the man was 
found seizing. When paramedics arrived the patient remained 
unresponsive and apneic with a wide QRS complex on the 
cardiac monitor.
The patient’s medical history included diabetes mellitus, 
diabetic nephropathy requiring hemodialysis three times per 
week, and severe coronary artery disease. He had a coronary 
artery  bypass  graft  and  a  pacemaker.  He  was  dialyzed  one 
day prior to presentation and had otherwise been in his usual 
health.
Upon presentation to the Emergency Department, the patient was 
unresponsive and apneic. He had a blood pressure of 46/66 mm Hg, 
a palpable pulse at 55 beats per minute, and depressed respirations 
requiring assisted ventilation by bag valve mask. External cardiac 
monitoring revealed a wide QRS rhythm. The patient smelled of 
oil of wintergreen. Head and neck exam was normal. His lungs 
were clear and his heart without murmurs. Abdominal and rectal 
exam  were  unremarkable.  His  lower  extremities  demonstrated 
acrocyanosis and were cool to touch. Diminished pulses were noted, 
and no reflexes were elicited. His bilateral forearm shunts appeared 
intact.
Resuscitation  in  the  Emergency  Department  consisted  of 
oral  endotracheal  intubation,  followed  by  gastric  lavage  and 
administration of activated charcoal. The patient initial arterial blood 
gas on FiO2 00% was pH 6.95, pCO2 34 mmHg, pO2 400 mmHg, 
and the patient was given intravenous sodium bicarbonate. The serum 
potassium level was 8.6 mmol/L and the patient was given 1 gm of 
calcium gluconate intravenously. His electrocardiogram showed a 
wide complex QRS with pacemaker depolarizations at 80 spikes 
per minute. The patient also developed several runs of ventricular 
tachycardia, which responded to mg/kg (75 mg) lidocaine.
The patient’s chest radiograph demonstrated cardiomegaly with 
no evidence of pulmonary edema. The endotracheal tube was in 
good position above the carina. Serum chemistries revealed the 
following  values:  sodium  134  mmol/L,  potassium  8.6  mmol/L, 
chloride 97 mmol/L, bicarbonate 6 mmol/L, urea nitrogen 62 mmol/
L, creatinine 6.9 mmol/L. He had an anion gap of 3 (normal < 4). 
His salicylate level was 74.8 mg/dl.
Immediate  hemodialysis  was  initiated  upon  transfer  to  the 
Intensive Care Unit. Repeat arterial blood gas after  /2 hrs of 
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These  effects  cause  hyperpnea,  tachypnea,  tachycardia,  fever, 
hemorrhage, and hypoglycemia, all of which can subsequently 
progress to altered mental status and seizures.4,5  
Factors  that  affect  the  rate  of  percutaneous  absorption  of 
salicylate include: the effect of salicylic acid on the epidermis, 
the pathologic state of the skin, the degree of hydration of the 
stratum corneum, and the solvents used. Strakosch studied the 
histological changes of the skin caused by the application of 
salicylate in concentrations ranging from % to 5%.
5
 His studies 
were conducted on the normal skin of volunteers. Depending on 
the concentration of the salicylate and on the ointment base used, 
the salicylate ointments caused injury to the epidermis within two 
to 14 days. On histological examination, the findings included 
swelling and exfoliation of the stratum corneum. He also showed 
that the addition of 3% or 6% sulfur to 3% salicylate accelerated 
the onset of swelling and exfoliation of the stratum corneum.
6
  
It is likely that compromised epidermis, by exposing viable 
cells, is a significant factor in the percutaneous penetration of 
salicylates.
7 
In both animal models and human subjects, the rate 
of  percutaneous  penetration  of  salicylate  in  various  ointment 
bases  was  determined  by  measuring  the  serum  concentration 
and urinary output of salicylates.8,9 Both studies demonstrated 
significant  absorption  of  salicylate,  especially  in  hydrophilic 
ointment base. 
The severity of toxicity can generally be predicted from the 
amount of drug absorbed. Ingestion of less than 50 mg/kg is 
usually not associated with systemic toxicity; 50-300 mg/kg may 
produce mild to moderate symptoms of hyperpnea and neurologic 
disturbances (lethargy and/or excitability). A dose of greater than 
500 mg/kg of salicylate can result in severe hyperpnea, coma, 
and occasionally seizures.
0
About 20% of the salicylate is oxidized in the tissues and 
70% is excreted by the kidneys.3 Because the hepatic enzymatic 
metabolism  becomes  saturated  as  salicylate  levels  increase, 
renal excretion becomes increasingly important as a means of 
elimination.2,,2  Therefore, renal insufficiency or renal failure 
contributes to further accumulation of salicylate.
The  treatment  of  acute  salicylate  intoxication  consists  of 
decreasing  further  absorption  of  salicylates,  enhancing  drug 
elimination, and correcting for acid-base, fluid, and electrolyte 
imbalances. Gastric lavage has not demonstrated to be better than 
charcoal alone at reducing toxicity in an evidence-based review.
3
 
Extra doses of activated charcoal may be needed to achieve the 
desired ration of 0: activated charcoal to salicylates. Repeated 
doses of activated charcoal may enhance elimination through 
enteroenteric recirculation.
4
 
Prompt  correction  of  systemic  acidosis  with  sodium 
bicarbonate  is  critical  to  prevent  further  transfer  of  unbound 
salicylate into the CNS. Alkalization of the urine with sodium 
bicarbonate (2-3 mEq/kg loading dose intravenously, and 2 mEq/
kg every 3-4 hours thereafter to maintain a urine pH above 8) 
will enhance urinary excretion of salicylate and reduce serum 
half-life.7,  Overly  vigorous  fluid  administration  can  lead  to 
pulmonary edema or cerebral edema. Fluid or osmotic diuresis 
47 mmHg. Repeat potassium was 4.3 mmol/L.
Approximately nine hours after admission, the patient had 
another  generalized  tonic-clonic  seizure,  which  responded 
to diazepam. However, because the patient desired no heroic 
measures,  no  resuscitative  efforts  were  performed  when  he 
continued to deteriorate.
An autopsy revealed a postmortem salicylate level of 82.6 
mg/dl; 7.8 mg/dl higher than his pre-dialysis level, and the cause 
of death was determined to be acute salicylate intoxication. It 
was concluded that the cause of salicylate toxicity in this patient 
was due to continued dermal absorption of oil of wintergreen in 
this patient with chronic renal failure. 
DISCUSSION
Salicylate  intoxication  can  produce  serious  morbidity  and 
mortality after accidental or intentional acute ingestion, or chronic 
over-medication. Percutaneous absorption of salicylates may also 
result in toxicity, especially in patients with renal failure.
Prior to antibiotics, topical salicylates were widely used to 
treat scabies and impetigo, and toxicity associated with dermal 
absorption was common. One case series reported 3 deaths, 
0 of them in children, substantiating the severe potential for 
toxicity associated with this route. A  review of the literature 
of topical salicylates reported 7 documented cases of toxicity 
associated with underlying illnesses, days to diagnosis,  and serum 
salicylate.2 Psoriasis is the main entity still treated with topical 
salicylates, and there are numerous case reports documenting 
toxicity.,2  Another route of application is with sports creams 
used in massage therapy for muscle pain.  Local skin necrosis 
and interstitial nephritis have also been associated with these 
creams.2
Our patient experienced seizures with a salicylate level of 74.8 
mg/dl  and  was  hemodialyzed  immediately  upon  presentation, 
which should have lowered his serum salicylate level. However, 
his subsequent serum level was 82.6 mg/dl. Despite aggressive 
treatment with intubation, gastric lavage, charcoal, bicarbonate, 
and dialysis, his salicylate level continued to increase. It is likely 
that  percutaneous  penetration  of  salicylate  contributed  to  his 
rising level. No efforts were made to decontaminate his skin 
because it was thought to be insignificant at that time.
Methyl salicylate (oil of wintergreen) contains more salicylate 
than other salicylates; 5 ml methyl salicylate is equivalent to five 
aspirin tablets (325 mg each).
The primary effects of salicylate toxicity are complex and 
include direct stimulation of the CNS respiratory center leading 
to  a  respiratory  alkalosis.  Salicylates  also  uncouple  oxidative 
phosphorylation  at  a  cellular  level,  producing  an  increased 
metabolic rate. This results in increasing oxygen consumption, 
glucose utilization, and heat production.4  Salicylates inhibit the 
Krebs cycle and alter lipid metabolism and amino acid metabolism, 
producing  lactic  acid  and  ketones  with  resultant  metabolic 
acidosis.  4  They  also  interfere  with  hemostasis  by  damaging 
hepatocytes  and  interfering  with  prostaglandin  synthesis. The California Journal of Emergency Medicine VIII: February 2007  Page 25
does  not  increase  renal  salicylate  excretion  more  than  urinary 
alkalization.
2
Hemodialysis  is  the  most  efficient  method  of  removing 
salicylates from the blood. Dialysis is the treatment of choice in 
salicylate-intoxicated patients who have severe renal, hepatic, or 
cardiovascular disorders, uncorrectable acidosis, comatose, seizing, 
or are unresponsive to other methods of treatment.
                               SUMMARY
Salicylate  toxicity  from  percutaneous  absorption  can  occur, 
especially with methyl salicylate.  Renal dialysis patients are at 
increased  risk  for  salicylism  because  salicylates  are  primarily 
excreted by the kidneys.  Physicians should be aware of the potential 
risks of salicylate dermal absorption and toxicity.
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